000 | 01823 a2200541 4500 | ||
---|---|---|---|
005 | 20250513211147.0 | ||
264 | 0 | _c20000907 | |
008 | 200009s 0 0 eng d | ||
022 | _a0168-8227 | ||
024 | 7 |
_a10.1016/s0168-8227(00)00129-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYamamoto, T | |
245 | 0 | 0 |
_aClinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report. _h[electronic resource] |
260 |
_bDiabetes research and clinical practice _cJul 2000 |
||
300 |
_a65-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAutoantibodies _ximmunology |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 |
_aC-Peptide _xblood |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
650 | 0 | 4 | _aDesensitization, Immunologic |
650 | 0 | 4 | _aGlucose Tolerance Test |
650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperglycemia _xdrug therapy |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aInsulin Resistance _ximmunology |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPlasma Exchange |
650 | 0 | 4 | _aPlasmapheresis |
650 | 0 | 4 |
_aReceptor, Insulin _ximmunology |
650 | 0 | 4 |
_aSyncope _ximmunology |
700 | 1 | _aSato, T | |
700 | 1 | _aMori, T | |
700 | 1 | _aYamakita, T | |
700 | 1 | _aHasegawa, T | |
700 | 1 | _aMiyamoto, M | |
700 | 1 | _aHosoi, M | |
700 | 1 | _aIshii, T | |
700 | 1 | _aYoshioka, K | |
700 | 1 | _aTanaka, S | |
700 | 1 | _aFujii, S | |
773 | 0 |
_tDiabetes research and clinical practice _gvol. 49 _gno. 1 _gp. 65-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-8227(00)00129-7 _zAvailable from publisher's website |
999 |
_c10759935 _d10759935 |